1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. BeiGene, Ltd.
  6. News
  7. Summary
    BGNE   US07725L1026

BEIGENE, LTD.

(BGNE)
  Report
Delayed Nasdaq  -  04:00 2022-08-12 pm EDT
193.97 USD   -1.36%
08/10BEIGENE : Announces Positive Global Phase 3 Trial Results for PD-1 Inhibitor Tislelizumab in First-Line Unresectable Hepatocellular Cancer - Form 8-K
PU
08/10BEIGENE, LTD. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
08/10Asian ADRs Move Sharply Higher in Wednesday Trading
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

European ADRs Rise Sharply in Tuesday Trading

06/21/2022 | 11:01am EDT


© MT Newswires 2022
Stocks mentioned in the article
ChangeLast1st jan.
AKARI THERAPEUTICS, PLC -0.99% 1.4851 Delayed Quote.-0.99%
ASLAN PHARMACEUTICALS LIMITED 22.91% 0.8481 Delayed Quote.-24.28%
AUTOLUS THERAPEUTICS PLC 3.18% 3.57 Delayed Quote.-31.21%
BEIGENE, LTD. -1.36% 193.97 Delayed Quote.-28.41%
BICYCLE THERAPEUTICS PLC 1.31% 26.25 Delayed Quote.-56.88%
CANGO INC. -0.37% 2.68 Delayed Quote.-14.65%
CELLECTIS S.A. -0.28% 3.614 Real-time Quote.-51.42%
CHINA ONLINE EDUCATION GROUP 2.25% 1.6258 Delayed Quote.34.36%
EDAP TMS S.A. 2.32% 7.49 Delayed Quote.25.04%
FORWARD PHARMA A/S 0.27% 3.76 Delayed Quote.-37.02%
FRESENIUS MEDICAL CARE AG & CO. KGAA -0.81% 36.65 Delayed Quote.-35.86%
FRESENIUS SE & CO. KGAA -0.49% 24.57 Delayed Quote.-30.59%
GENFIT -4.99% 4.46 Real-time Quote.3.34%
GRAVITY CO., LTD. 0.15% 52.53 Delayed Quote.-22.89%
INFOSYS LIMITED -1.60% 1594.1 Delayed Quote.-15.56%
JD.COM, INC. 0.19% 57.05 Delayed Quote.-18.58%
LONDON BRENT OIL -1.47% 97.84 Delayed Quote.27.42%
MORPHOSYS AG 0.39% 23.15 Delayed Quote.-30.58%
NATIONAL GRID PLC 0.66% 1139.5 Delayed Quote.7.52%
PHOENIX NEW MEDIA LIMITED -0.61% 4.9 Delayed Quote.-5.26%
PLDT INC. 0.39% 1818 End-of-day quote.0.33%
SEA LIMITED 0.15% 88.71 Delayed Quote.-60.35%
SECOO HOLDING ADR A -5.50% 0.263 Delayed Quote.-45.21%
SPARK NETWORKS SE 1.35% 3 Delayed Quote.-4.46%
WIPRO LIMITED -0.51% 436.15 End-of-day quote.-39.02%
WTI -2.31% 91.866 Delayed Quote.24.73%
ZAI LAB LIMITED -1.84% 44.17 Delayed Quote.-29.72%
All news about BEIGENE, LTD.
08/10BEIGENE : Announces Positive Global Phase 3 Trial Results for PD-1 Inhibitor Tislelizumab ..
PU
08/10BEIGENE, LTD. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
08/10Asian ADRs Move Sharply Higher in Wednesday Trading
MT
08/09JPMorgan Assumes BeiGene at Overweight with $296 Price Target
MT
08/09Novartis-BeiGene Liver Cancer Drug Works As Well As Bayer's Nexavar in Phase 3 Study
MT
08/09BeiGene Announces Positive Global Phase 3 Trial Results for PD-1 Inhibitor Tislelizumab..
BU
08/09BeiGene Announces Positive Global Phase 3 Trial Results for PD-1 Inhibitor Tislelizumab..
CI
08/08BEIGENE, LTD. Management's Discussion and Analysis of Financial Condition and Results ..
AQ
08/08Nomura Adjusts BeiGene's Price Target to $286.31 From $277.35, Maintains Buy Rating
MT
08/08Nomura Adjusts Beigene's Price Target to HK$172.89 From HK$167.48, Keeps at Buy
MT
More news
Analyst Recommendations on BEIGENE, LTD.
More recommendations
Financials (USD)
Sales 2022 1 395 M - -
Net income 2022 -1 618 M - -
Net cash 2022 2 884 M - -
P/E ratio 2022 -15,9x
Yield 2022 -
Capitalization 20 070 M 20 070 M -
EV / Sales 2022 12,3x
EV / Sales 2023 8,88x
Nbr of Employees 8 600
Free-Float 99,0%
Chart BEIGENE, LTD.
Duration : Period :
BeiGene, Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BEIGENE, LTD.
Short TermMid-TermLong Term
TrendsBullishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 16
Last Close Price 193,97 $
Average target price 274,75 $
Spread / Average Target 41,6%
EPS Revisions
Managers and Directors
John V. Oyler Director
Xiao Bin Wu President & Chief Operating Officer
Julia Wang Chief Financial & Accounting Officer
Lai Wang Global Head-Research & Development
Christiane Langer Senior Vice President-Global Medical Affairs
Sector and Competitors
1st jan.Capi. (M$)
BEIGENE, LTD.-28.41%20 070
GILEAD SCIENCES, INC.-13.29%78 273
VERTEX PHARMACEUTICALS34.12%74 927
REGENERON PHARMACEUTICALS, INC.-0.45%66 700
WUXI APPTEC CO., LTD.-20.10%40 674
BIONTECH SE-37.80%38 540